
AngioDynamics, Inc.
ANGO·NASDAQ
Last updated as of 2026-06-30 10:16 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
ANGO stock price change
On the last trading day, ANGO stock closed at 13.11 USD, with a price change of -2.20% for the day.
Trade spot stocks (24/7)Bitget's stock quote pages provide comprehensive information on ANGO stock, including real-time prices, historical price charts, key data, price performance analysis, daily briefings, analyst forecasts, the latest news, business overviews, and financial analysis—all in one place. You can access real-time stock price information for AngioDynamics, Inc. (ANGO), including 24-hour price movements, historical price charts, 52-week high and low ranges, market capitalization, trading volume, and key financial metrics such as price-to-earnings ratio, quarterly revenue, and earnings per share. You can also stay up to date on AngioDynamics, Inc.'s stock price outlook and latest developments through analyst consensus price targets and curated news coverage. Information sources include NASDAQ stock exchange data, TradingView data, AngioDynamics, Inc. financial reports, analysis from leading Wall Street institutions and analysts, and articles from major financial media outlets.
ANGO key data
Previous close13.11 USD
Market cap541.48M USD
Volume150.27K
P/E ratio-
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)-0.76 USD
Net income (FY)−33.99M USD
Revenue (FY)292.50M USD
Next report dateJul 21, 2026
EPS estimate-
Revenue estimate80.24M USD USD
Shares float36.55M
Beta (1Y)0.59

Bitget ushers in the Stocks 2.0 era:
A new way to trade stocks — anytime, anywhere, 24/7.
Access Wall Street liquidity, dividend payouts, and futures margin support.
Learn moreAngioDynamics, Inc. overview
Sector
Health technology
Industry
Medical Specialties
CEO
James Christopher Clemmer
Headquarters
Latham
Website
angiodynamics.com
Founded
1988
Employees (FY)
675
Change (1Y)
−73 −9.76%
Revenue / Employee (1Y)
433.33K USD
Net income / Employee (1Y)
−50.36K USD
ANGO stock price forecast
According to technical indicators for ANGO stock, the price is likely to fluctuate within the range of 12.60–16.22 USD over the next week. Market analysts predict that the price of ANGO stock will likely fluctuate within the range of 11.12–21.38 USD over the next months.
Based on 1-year price forecasts from 29 analysts, the highest estimate is 24.76 USD, while the lowest estimate is 9.22 USD.
For more information, please see the
ANGO stock price forecast
page.
Trending stocks
Trade spot stocks on Bitget
Trade stock perps on Bitget
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
To provide deeper liquidity, a more transparent trading experience, and greater capital efficiency, Bitget officially launched its all-new spot stock product, Bitget Stocks 2.0, on June 2, 2026.
The new product is independently issued by licensed RWA protocol Reality, with Bitget providing strategic support and asset security safeguards. This marks a major upgrade to the stock trading experience.
Bitget is moving stock trading beyond the limits of traditional trading models by fully integrating stock assets into its margin and yield ecosystem.
Learn moreLatest ANGO stock news
Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
Finviz2026-02-13 19:12:40
Here's How Veracyte Stock Is Placed Ahead of Q4 Earnings
Finviz2026-02-16 14:57:44
ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation
Finviz2026-02-23 18:48:05
Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors
Finviz2026-02-26 13:03:43
AngioDynamics (ANGO) recently released its financial report for the third quarter of fiscal year 2026.
老虎证券2026-04-02 10:08:06
Medical device company AngioDynamics has taken legal action by officially filing a patent infringement lawsuit against Endovascular Engineering on April 23, 2026.
老虎证券2026-04-23 21:30:05
AngioDynamics announces a key advancement for its NanoKnife Irreversible Electroporation (IRE) System as it achieves Medicare coverage.
老虎证券2026-05-28 17:39:41
AngioDynamics announced that its Relief feasibility study, which aims to evaluate the Nanoknife irreversible electroporation (IRE) platform as a minimally invasive treatment option for benign prostatic hyperplasia (BPH), has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA).
老虎证券2026-06-17 12:34:51
Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
Finviz2026-02-13 19:12:40
Here's How Veracyte Stock Is Placed Ahead of Q4 Earnings
Finviz2026-02-16 14:57:44
ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation
Finviz2026-02-23 18:48:05
Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors
Finviz2026-02-26 13:03:43
AngioDynamics (ANGO) recently released its financial report for the third quarter of fiscal year 2026.
老虎证券2026-04-02 10:08:06